152 results on '"Magnani, Alessandra"'
Search Results
2. Modalités et impact de la cryopréservation des greffons allogéniques en contexte pandémique : recommandations de la SFGM-TC
3. Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial
4. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
5. Humanized in vivo bone marrow models orchestrate multi-lineage human hematopoietic cell development
6. Retrieval of vector integration sites from cell-free DNA
7. Procédé de préparation, contrôles de qualité et spécifications des immunosélections CD34+ : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
8. Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children
9. Correction to: Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy
10. Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy
11. Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients
12. THE WATER STEWARDSHIP APPROACH TOWARDS RESILIENT WATER USE.
13. Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1
14. Caratteristiche e percorsi in persone in carico al SerDP: l'uso dell'MMPI-2
15. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease
16. Supplement to: Gene thereapy in a patient with sickle cell disease.
17. Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease
18. Gene Therapy in a Patient with Sickle Cell Disease: Brief Report
19. Bayesian Modeling Immune Reconstitution Apply to CD34+ Selected Stem Cell Transplantation for Severe Combined Immunodeficiency
20. A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy
21. Rapid and Safe T Cell Immune Reconstitution By T Cell Progenitor Injection Following Haploidentical Transplantation for Severe Combined Immunodeficiency (SCID)
22. Long-Term Follow-up Study after Lentiviral Hematopoietic Stem/Progenitor Cell Gene Therapy for Wiskott - Aldrich Syndrome
23. Clinical Results of the Drepaglobe Trial for Sickle Cell Disease Patients
24. Antinuclear antibody–positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis
25. Vascular access for optimal hematopoietic stem cell collection
26. Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programs
27. A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy.
28. Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease
29. Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma
30. A New Step in Understanding of Fanconi Patients Peripheral Stem Cell Harvesting, a Bridge to Gene Therapy
31. Modeling of Immune Reconstitution Post CD34 Selected Stem Cell Transplantation in Pediatric Patients with Severe Combined Immune Deficiency
32. Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy
33. Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy
34. Successful in utero stem cell transplantation in X-linked severe combined immunodeficiency
35. Vascular access for optimal hematopoietic stem cell collection.
36. Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
37. Analysis of RBC Properties in Patients with SCD Treated with Lentiglobin Gene Therapy
38. Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
39. Successful haematopoietic stem cell transplantation in a case of pulmonary alveolar proteinosis due to GM-CSF receptor deficiency
40. a Diversity of Human Hematopoietic Differentiation Programs Identified through In Vivo Tracking of Hematopoiesis in Wiskott-Aldrich Syndrome Patients
41. Modalités de préparation, cryopréservation, décongélation des cellules souches hématopoïétiques et précautions pour infusion au patient : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
42. B CELL RECONSTITUTION AFTER GENE THERAPY IN PATIENTS WITH WISKOTT ALDRICH SYNDROME (WAS) AND COMPARISON WITH MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
43. IMMUNOLOGICAL RECONSTITUTION AFTER IN UTERO STEM CELL TRANSPLANTATION IN A SCID-γc FOETUS
44. 754. Exploring the Human Hematopoietic Hierarchy Through Retroviral Integration Sites Tracking in the Wiskott Aldrich Syndrome Gene Therapy Trial
45. 231. Mixed Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation in Sickle Cell Disease: Preliminary Results on Peripheral Blood Sorted Subpopulations and Erythroid Progenitors
46. B Cell Reconstitution after Gene Therapy in Patients with Wiskott Aldrich Syndrome and Comparison with Mismatched Allogeneic Hematopoietic Stem Cell Transplantation
47. Human Pro-T-Cell Manufacturing in Vitro Is a Safe Procedure for Hematopoietic Stem Cell Transplantation with Delayed T-Cell Reconstitution: Interim Results from 2 Different Clinical Trials
48. Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells
49. Successful haematopoietic stem cell transplantation in a case of pulmonary alveolar proteinosis due to GM-CSF receptor deficiency.
50. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.